The Board of Directors of Eisai Co., Ltd. has authorized a buyback plan on May 15, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6,753 JPY | +2.71% | -0.16% | -4.24% |
May. 24 | BioArctic, Eisai's Azlheimer’s Disease Drug Wins Regulatory Nod in South Korea | MT |
May. 16 | Eisai's Attributable Profit Falls 23.5% in Fiscal 2024 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.24% | 12.32B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- 4523 Stock
- News Eisai Co., Ltd.
- Eisai Co., Ltd. authorizes a Buyback Plan.